Coumarins (warfarin, acenocoumarol, phenprocuomon) are well known agents that are prescribed for prevention of thromboembolic episodes in pregnant women who are on mechanical heart valves prosthesis. It acts as double edge sword as fetus is unnecessarily exposed to teratogenic effect of drug. Warfarin is well studied drug in terms of its tetratogenic dose, period of exposure, fetopathic effects. Acenocoumarol is well known teratogen but its effect and lethal dose on fetus is less reported. We report a neonate who was exposed to acenocoumarol throughout intra uterine life. Neonate showed all features of coumarin embryopathy (flat facial profile, depressed nasal bridge, short columella, skeletal stippling, short distal phalanges in hand) and cephalhaematoma in addition. We also summarised the clinical findings of all the cases reported so far of acenocoumarol embryopathy. Acenocoumarol has same teratogenic potential as of warfarin. Doses causing embryopathy remained unexplored field. Clinicians need to document properly so that scientific data can be generated as ethical issues arises in head to head trial of these drugs.
Acenocoumarol Embryopathy Chondrodysplasia Calcification Mid face hypoplasia
This is a preview of subscription content, log in to check access.
AS and AP collected the data and AS conceptualized the idea and wrote the manuscript and is first author. RP helped in case management and manuscript writing. OPM critically analysed the manuscript.
Compliance with Ethical Standards
Conflict of interest
The authors declared that they have no conflict of interest.
Ban A. Long-term treatment with coumarin preparations in advanced age. Z Gesamte Inn Med. 1984;39:617–20.PubMedGoogle Scholar
Van Driel D, Wesseling J, Sauer PJ, et al. Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology. 2002;66:127–40.CrossRefPubMedGoogle Scholar
McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res. 2011;127:S56–60.CrossRefPubMedGoogle Scholar
Panduranga P, El-Deeb M, Jha C. Mechanical prosthetic valves and pregnancy: a therapeutic dilemma of anticoagulation. Sultan Qaboos Univ Med J. 2014;14:e448–54.PubMedPubMedCentralGoogle Scholar
Suri V, Keepanasseril A, Aggarwal N, et al. Mechanical valve prosthesis and anticoagulation regimens in pregnancy: a tertiary centre experience. Eur J Obstet Gynecol Reprod Biol. 2011;159:320–3.CrossRefPubMedGoogle Scholar
Prieto AL, Weber JL, Tracy S, et al. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system. Brain Res. 1999;816:646–61.CrossRefPubMedGoogle Scholar
Becker MH, Genieser NB, Finegold M, et al. Chondrodysplasia Punctata. Is maternal warfarin therapy a factor? Am J Dis Child. 1975;129:356–9.CrossRefPubMedGoogle Scholar
Howe AM, Webster WS. Vitamin K: its essential role in craniofacial development. A review of the literature regarding vitamin K and craniofacial development. Aust Dent J. 1994;39:88–92.CrossRefPubMedGoogle Scholar
Vanlaeys R, Deroubaix P, Deroubaix G, et al. Les antivitamines K sont-elles te´ratoge`nes? Nouv Press Med. 1977;6:756.Google Scholar
Weenink GH, van Dijk-Wierda CA, Meyboom RH, et al. Teratogenic effect of coumarin derivatives. Ned Tijdschr Geneeskd. 1981;125:702–6.PubMedGoogle Scholar
Lapiedra OJ, Bernal JM, Ninot S, et al. Open heart surgery for thrombosis of a prosthetic mitral valve during pregnancy. Fetal hydrocephalus. J Cardiovasc Surg (Torino). 1986;27:217–20.Google Scholar
De Vries TW, Van der Veer E, Heymans HSA. Warfarin embryopathy: patient, possibility, pathogenesis and prognosis. Br J Obstet Gynaecol. 1993;100:869–71.CrossRefPubMedGoogle Scholar
Van Driel D, Wesseling J, De Vries TW, et al. Coumarin embryopathy: follow-up of two cases. Eur J Pediatr. 2002;161:231–2.CrossRefPubMedGoogle Scholar
Robinow M, Johnson GF. Dermatoglyphics in distal phalangeal hypoplasia. Am J Dis Child. 1972;124:860–3.PubMedGoogle Scholar
Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis. Interact CardioVasc Thorac Surg. 2014;18:797–806.CrossRefPubMedGoogle Scholar
Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122–40.CrossRefPubMedGoogle Scholar